Higher comorbidities and early death in hospitalized African-American patients with Covid-19.
Raavi GuptaRaag AgrawalZaheer BukhariAbsia JabbarDonghai WangJohn DiksMohamed AlshalDokpe Yvonne EmechebeF Charles BrunicardiJason M LazarRobert ChamberlainAaliya BurzaM A HaseebPublished in: BMC infectious diseases (2021)
COVID-19 patients in our predominantly Black neighborhood had higher in-hospital mortality, likely due to higher prevalence of comorbidities. Early dialysis and pre-admission intake of ACE inhibitors/ARBs improved patient outcomes. Early escalation of care based on comorbidities and key laboratory indicators is critical for improving outcomes in African-American patients.
Keyphrases
- african american
- end stage renal disease
- chronic kidney disease
- healthcare
- emergency department
- peritoneal dialysis
- newly diagnosed
- ejection fraction
- palliative care
- risk factors
- sars cov
- randomized controlled trial
- body mass index
- quality improvement
- adipose tissue
- angiotensin ii
- pain management
- angiotensin converting enzyme
- study protocol
- health insurance
- weight loss